These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2656909)

  • 1. Maturation of immunoglobulin G avidity after rubella vaccination studied by an enzyme linked immunosorbent assay (avidity-ELISA) and by haemolysis typing.
    Hedman K; Hietala J; Tiilikainen A; Hartikainen-Sorri AL; Räihä K; Suni J; Väänänen P; Pietiläinen M
    J Med Virol; 1989 Apr; 27(4):293-8. PubMed ID: 2656909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of avidity of specific IgG for verification of recent primary rubella.
    Hedman K; Rousseau SA
    J Med Virol; 1989 Apr; 27(4):288-92. PubMed ID: 2723615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Avidity of immunoglobulin G to rubella virus in post-vaccination and post-infection immunity].
    Desiatskova RG; Zargar'iants AI; Stepanov AV; Zverev VV
    Zh Mikrobiol Epidemiol Immunobiol; 2007; (4):6-11. PubMed ID: 17882830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rubella IgG total antibody avidity and IgG subclass-specific antibody avidity assay and their role in the differentiation between primary rubella and rubella reinfection.
    Enders G; Knotek F
    Infection; 1989; 17(4):218-26. PubMed ID: 2767764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of IgM enzyme immunoassay and IgG avidity assay for distinguishing between primary and secondary immune response to rubella vaccine.
    Hamkar R; Jalilvand S; Mokhtari-Azad T; Nouri Jelyani K; Dahi-Far H; Soleimanjahi H; Nategh R
    J Virol Methods; 2005 Dec; 130(1-2):59-65. PubMed ID: 16026863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibody response to live rubella vaccination and its clinical meanings].
    Hoshiba T; Yabuki Y; Asamoto A; Kimura N; Tanaka J
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2029-35. PubMed ID: 3429985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a rapid and convenient method for determination of rubella virus-specific immunoglobulin G avidity.
    Vauloup-Fellous C; Ursulet-Diser J; Grangeot-Keros L
    Clin Vaccine Immunol; 2007 Nov; 14(11):1416-9. PubMed ID: 17913862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Demonstration of Rubella-specific IgG and IgM antibody (sub) classes using the enzyme immunoassay (EIA)].
    Doerr HW; Fleischer G; Wiesmann M
    Immun Infekt; 1984 Feb; 12(1):21-8. PubMed ID: 6398271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of determining low-avidity IgG antibodies in the diagnosis of primary rubella infection in pregnant women].
    Lafarga B; Noguera FJ; Pérez MC; Copado R; García A; Soria E
    Enferm Infecc Microbiol Clin; 1998 Nov; 16(9):413-8. PubMed ID: 9887628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of recent primary rubella virus infections: significance of glycoprotein-based IgM serology, IgG avidity and immunoblot analysis.
    Wandinger KP; Saschenbrecker S; Steinhagen K; Scheper T; Meyer W; Bartelt U; Enders G
    J Virol Methods; 2011 Jun; 174(1-2):85-93. PubMed ID: 21513745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection.
    Thomas HI; Morgan-Capner P
    Epidemiol Infect; 1988 Dec; 101(3):591-8. PubMed ID: 3215288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential IgG avidity to rubella virus structural proteins.
    Mauracher CA; Mitchell LA; Tingle AJ
    J Med Virol; 1992 Mar; 36(3):202-8. PubMed ID: 1564450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of low-avidity immunoglobulin G in oral fluid samples: new approach for rubella diagnosis and surveillance.
    Akingbade D; Cohen BJ; Brown DW
    Clin Diagn Lab Immunol; 2003 Jan; 10(1):189-90. PubMed ID: 12522062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of protein-denaturing immunoassays for avidity of immunoglobulin G to rubella virus.
    Polanec J; Seppälä I; Rousseau S; Hedman K
    J Clin Lab Anal; 1994; 8(1):16-21. PubMed ID: 8164106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Microtiter enzyme-linked immunosorbent assay for rubella antibodies in human sera--analysis by parallel line assay method].
    Morita M; Suzuki T; Suzuki Y; Hoshino H
    Kansenshogaku Zasshi; 1992 Aug; 66(8):1075-83. PubMed ID: 1402112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines.
    de Souza VA; Pannuti CS; Sumita LM; de Andrade Júnior HF
    J Med Virol; 1997 Jul; 52(3):275-9. PubMed ID: 9210036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing between primary infection and reinfection with rubella vaccine virus by IgG avidity assay in pregnant women.
    Hamkar R; Jalilvand S; Abdolbaghi MH; Jelyani KN; Esteghamati A; Hagh-goo A; Mohktari-Azad T; Nategh R
    East Mediterr Health J; 2009; 15(1):94-103. PubMed ID: 19469431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maturation of IgG avidity to individual rubella virus structural proteins.
    Nedeljkovic J; Jovanovic T; Oker-Blom C
    J Clin Virol; 2001 Aug; 22(1):47-54. PubMed ID: 11418352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturation of rubella IgG avidity over time after acute rubella infection.
    Böttiger B; Jensen IP
    Clin Diagn Virol; 1997 Aug; 8(2):105-11. PubMed ID: 9316732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of rubella virus antibodies indicating immunity: response to vaccination of subjects with low or undetectable antibody concentrations.
    Matter L; Kogelschatz K; Germann D
    J Infect Dis; 1997 Apr; 175(4):749-55. PubMed ID: 9086126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.